Globus Medical
GMED
#1824
Rank
$7.57 B
Marketcap
$75.86
Share price
0.90%
Change (1 day)
19.13%
Change (1 year)

P/E ratio for Globus Medical (GMED)

P/E ratio as of January 2023 (TTM): 49.1

According to Globus Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 49.1201. At the end of 2021 the company had a P/E ratio of 48.8.

P/E ratio history for Globus Medical from 2012 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202148.8-22.21%
202062.768.28%
201937.337.77%
201827.0-26.29%
201736.759.74%
201623.0-2.56%
201523.6-2.8%
201424.3-11.06%
201327.3115.77%
201212.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
39.3-20.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-9.33-119.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-114-331.27%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.